Rate My Professor Ganesh Venkatraman

Ganesh Venkatraman's primary research focus is molecular oncology within the Medicine faculty, exploring cancer mechanisms such as PAK1 signaling, metabolic rewiring in cancer cells, heme metabolism dysregulation, and drug repositioning strategies. Key research interests include tumors, cancer, cancer animal models, biotechnology, and cancer cells. He has contributed 112 publications, accumulating over 2,587 citations. Notable publications encompass 'Activation of oncogenic signaling kinase PAK1 by ionising radiation in oesophageal squamous cell carcinoma' (2023), 'Emerging roles of PAK1 in re-wiring glucose metabolism in cancer' (2024), 'Dysregulated heme metabolism in cancer progression' (2025), 'Decoding P21 Activated Kinase-1 (PAK1) and Drug Repositioning Strategies for Cancer Therapy' (2026), 'Silver nanoparticles as an antibacterial agent for endodontic infections' (2025), 'Risk association of the nitric oxide synthase VNTR intron 4 a/b variant with diabetic nephropathy' (2024), and 'Functional Changes in the Fallopian Tube: Environmental Factors, Lifestyle, and Fertility' (year not specified). These works highlight his influence on cancer biology and therapeutic development through rigorous investigation of oncogenic pathways and novel interventions.